BiomarkersHumans
ApoE Genotyping and 12‐Month Longitudinal Tracking of p ‐Tau217 Using Fingerstick Collection in a Population‐Based Cohort
AAIC 2025 Abstract
Abstract
Background: Implementing recently approved disease‐modifying treatments for Alzheimer's disease (AD) requires healthcare systems to adapt rapidly. ApoE genotyping and determination of phosphorylated tau at Thr217 ( p ‐tau217) levels are essential for accurate patient selection and treatment response monitoring, respectively.
The paper
Laia Montoliu‐Gaya, Hanna Huber, Josep Blazquez, Xavier Morató Arús
Show 11 more authors
Luisa Sophie Braun-Wohlfahrt, Jakub Vávra, Berta Calm, Cañada Laia, Amanda Cano, Sergi Valero, Victoria M. Fernandez, Kaj Blennow, Henrik Zetterberg, Mercè Boada, Nicholas James Ashton,University of Gothenburg · Universitat Internacional de Catalunya
AAIC 2025 Abstract · 7 Jan 2026 · CC BY
Presented at AAIC 2025
